CytoDyn Inc.
CYDY
$0.20
$0.000.35%
OTC PK
| 05/31/2026 | 02/28/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 38.03% | -8.06% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.82% | 23.56% | |||
| Operating Income | -7.82% | -23.56% | |||
| Income Before Tax | -110.28% | 79.25% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -110.28% | 79.25% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -110.28% | 79.25% | |||
| EBIT | -7.82% | -23.56% | |||
| EBITDA | -7.83% | -23.61% | |||
| EPS Basic | -87.50% | 78.02% | |||
| Normalized Basic EPS | 21.43% | -40.00% | |||
| EPS Diluted | -87.50% | 80.00% | |||
| Normalized Diluted EPS | 21.43% | -40.00% | |||
| Average Basic Shares Outstanding | 7.33% | 1.12% | |||
| Average Diluted Shares Outstanding | 7.33% | 1.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||